Page last updated: 2024-09-02

oxymatrine and Disbacteriosis

oxymatrine has been researched along with Disbacteriosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Li, F; Li, J; Liang, J; Liu, J; Luo, Y; Sun, H; Sun, K; Yuan, W; Zeng, M; Zheng, H; Zhou, H1
Chen, XF; Chen, YL; Feng, KR; Kong, DX; Li, WX; Niu, L; Tang, JF; Wang, B; Wang, XY; Wu, CZ; Wu, YL; Yang, LQ; Zhang, H; Zhang, ML; Zhang, SQ1

Other Studies

2 other study(ies) available for oxymatrine and Disbacteriosis

ArticleYear
Oxymatrine ameliorates white matter injury by modulating gut microbiota after intracerebral hemorrhage in mice.
    CNS neuroscience & therapeutics, 2023, Volume: 29 Suppl 1

    Topics: Animals; Brain Injuries; Cerebral Hemorrhage; Dysbiosis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Inflammation; Mice; White Matter

2023
Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Animals; Blood-Brain Barrier; Dysbiosis; Encephalomyelitis, Autoimmune, Experimental; Gastrointestinal Microbiome; Homeostasis; Mice; Mice, Inbred C57BL; Multiple Sclerosis; RNA, Ribosomal, 16S; Sulfadiazine; Tandem Mass Spectrometry

2022